Nanosonics Limited (ASX:NAN)

Market Cap	1.24B
Revenue (ttm)	183.97M
Net Income (ttm)	16.56M
Shares Out	303.63M
EPS (ttm)	0.05
PE Ratio	76.69
Forward PE	64.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	378,210
Average Volume	811,525
Open	4.060
Previous Close	4.060
Day's Range	4.060 - 4.140
52-Week Range	2.670 - 5.180
Beta	1.76
RSI	34.37
Earnings Date	Aug 22, 2025

About Nanosonics

Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technolo...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 466
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: NAN

Financial Performance

In 2024, Nanosonics's revenue was 170.01 million, an increase of 2.42% compared to the previous year's 165.99 million. Earnings were 12.97 million, a decrease of -34.76%.